Biotech Innovent Receives Second Fast Track Designation from the U.S. FDA for IBI363 (PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Squamous Non-Small Cell Lung Cancer February 17, 2025
Biotech OraGen®, the first and only viable bone allograft, is now available for dental procedures February 16, 2025
Biotech Aramis Biotechnologies and the Biologics Manufacturing Centre Announce a Partnership February 15, 2025
Biotech DAAN Biotherapeutics Signs Antibody Exclusive Licensing Agreement with LigaChem Biosciences for ADC (Antibody-Drug Conjugate) Therapeutic Development February 13, 2025
Biotech Jazz Pharmaceuticals to Report 2024 Full Year and Fourth Quarter Financial Results on February 25, 2025 February 12, 2025
Biotech Bio X Cell Expands Global Reach with New Distribution Center in Beijing, China February 11, 2025
Biotech BioRay’s ROR1-Targeting Dual-Epitope ADC Drug BR111 Receives Formal Clinical Trial Approval from NMPA February 10, 2025
Biotech AMGEN TO PRESENT AT THE 35th ANNUAL OPPENHEIMER HEALTHCARE LIFE SCIENCES CONFERENCE February 9, 2025
Biotech Government of Canada invests $6 million to drive growth in B.C.’s life sciences sector February 8, 2025